Tarlatamab for SCLC Brain Metastases

Clinical trial NCT07402343 · RECRUITING

Trial details

NCT number: NCT07402343
Sponsor: Maastricht University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Brain Metastases, Adult

Start date: 2026-08-01
Primary completion: 2029-02-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.